Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, et al. Central nervous system cancers, version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(11):1537–70.

Article  Google Scholar 

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2021;18(3):170–86.

Article  Google Scholar 

Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Rudà R, et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017;18(6):e330–40.

Article  Google Scholar 

Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, et al. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. 2020;22(8):1073–113.

Article  CAS  Google Scholar 

Kazmi F, Soon YY, Leong YH, Koh WY, Vellayappan B. Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis. J Neurooncol. 2019;142(1):79–90.

Article  CAS  Google Scholar 

Lu VM, Goyal A, Graffeo CS, Perry A, Burns TC, Parney IF, et al. Survival benefit of maximal resection for glioblastoma reoperation in the temozolomide era: a meta-Analysis. World Neurosurg. 2019;127:31–7.

Article  Google Scholar 

Straube C, Scherb H, Gempt J, Kirschke J, Zimmer C, Schmidt-Graf F, et al. Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma—the GlioCave study (NOA 17–ARO 2016/3–DKTK ROG trial). BMC Cancer. 2018;18(1):15.

Article  Google Scholar 

Chun SJ, Park SH, Park CK, Kim JW, Kim TM, Choi SH, et al. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups. Radiother Oncol. 2018;128(2):254–9.

Article  Google Scholar 

Niyazi M, Adeberg S, Kaul D, Boulesteix AL, Bougatf N, Fleischmann DF, et al. Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: a multicenter DKTK/ROG analysis. Radiother Oncol. 2018;127(1):121–7.

Article  Google Scholar 

Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, et al. Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma. PLoS ONE. 2017;12(7):e0180457.

Article  Google Scholar 

Stöckelmaier L, Renovanz M, König J, Nickel K, Hickmann AK, Mayer-Steinacker R, et al. Therapy for recurrent high-grade gliomas: results of a prospective multicenter study on health-related quality of life. World Neurosurg. 2017;102:383–99.

Article  Google Scholar 

Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol. 2007;81(3):287–94.

Article  Google Scholar 

Dirven L, Reijneveld JC, Aaronson NK, Bottomley A, Uitdehaag BMJ, Taphoorn MJB. Health-related quality of life in patients with brain tumors: limitations and additional outcome measures. Curr Neurol Neurosci Rep. 2013;13(7):359.

Article  Google Scholar 

Audureau E, Chivet A, Ursu R, Corns R, Metellus P, Noel G, et al. Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model. J Neurooncol. 2018;136(3):565–76.

Article  Google Scholar 

Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry. 2005;76(4):562–8.

Article  CAS  Google Scholar 

Yokoo M, Akechi T, Takayama T, Karato A, Kikuuchi Y, Okamoto N, et al. Comprehensive assessment of cancer patients’ concerns and the association with quality of life. Jpn J Clin Oncol juill. 2014;44(7):670–6.

Article  Google Scholar 

Sacko A, Hou MM, Temgoua M, Alkhafaji A, Marantidou A, Belin C, et al. Evolution of the Karnosky Performance Status throughout life in glioblastoma patients. J Neurooncol mai. 2015;122(3):567–73.

Article  Google Scholar 

Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. JCO. 2010;28(11):1963–72.

Article  Google Scholar 

Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61–5.

CAS  Google Scholar 

Pasqualetti F, Montemurro N, Desideri I, Loi M, Giannini N, Gadducci G, et al. Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma. Acta Neurol Belg. 2022;122(2):441–6.

Article  Google Scholar 

Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ, et al. Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. Int J Radiat Oncol Biol Phys. 2011;81(3):623–30.

Article  Google Scholar 

Klobukowski L, Falkov A, Chelimo C, Fogh SE. A retrospective review of re-irradiating patients’ recurrent high-grade gliomas. Clin Oncol (R Coll Radiol). 2018;30(9):563–70.

Article  CAS  Google Scholar 

Yazici G, Cengiz M, Ozyigit G, Eren G, Yildiz F, Akyol F, et al. Hypofractionated stereotactic reirradiation for recurrent glioblastoma. J Neurooncol. 2014;120(1):117–23.

Article  Google Scholar 

Dincoglan F, Beyzadeoglu M, Sager O, Demiral S, Gamsiz H, Uysal B, et al. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy. Tumori. 2015;101(2):179–84.

Article  CAS  Google Scholar 

Pinzi V, Orsi C, Marchetti M, Milanesi IM, Bianchi LC, DiMeco F, et al. Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis. Neurol Sci. 2015;36(8):1431–40.

Article  Google Scholar 

Bräutigam E, Lampl C, Track C, Nieder C, Pichler J, Hammer J, et al. Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept. Clin Transl Oncol. 2019;21(5):582–7.

Article  Google Scholar 

Gigliotti MJ, Hasan S, Karlovits SM, Ranjan T, Wegner RE. Re-irradiation with stereotactic radiosurgery/radiotherapy for recurrent high-grade gliomas: improved survival in the modern era. Stereotact Funct Neurosurg. 2018;96(5):289–95.

Article  Google Scholar 

Aktan M, Koc M, Kanyilmaz G. Survival following reirradiation using intensity-modulated radiation therapy with temozolomide in selected patients with recurrent high grade gliomas. Ann Transl Med. 2015;3(20):304.

Google Scholar 

Zemlin A, Märtens B, Wiese B, Merten R, Steinmann D. Timing of re-irradiation in recurrent high-grade gliomas: a single institution study. J Neurooncol. 2018;138(3):571–9.

Article  CAS  Google Scholar 

Scoccianti S, Francolini G, Carta GA, Greto D, Detti B, Simontacchi G, et al. Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions. Crit Rev Oncol Hematol. 2018;126:80–91.

Article  Google Scholar 

Taunk NK, Moraes FY, Escorcia FE, Mendez LC, Beal K, Marta GN. External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. Expert Rev Anticancer Ther. 2016;16(3):347–58.

Article  CAS  Google Scholar 

Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol. 2008;92(2):185.

Article  Google Scholar 

Minniti G, Armosini V, Salvati M, Lanzetta G, Caporello P, Mei M, et al. Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma. J Neurooncol. 2011;103(3):683–91.

Article  CAS  Google Scholar 

Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol. 2009;185(4):235–40.

Article  Google Scholar 

Lederman G, Wronski M, Arbit E, Odaimi M, Wertheim S, Lombardi E, et al. Treatment of recurrent glioblastoma multiforme using fractionated stereotactic radiosurgery and concurrent paclitaxel. Am J Clin Oncol Cancer Clin Trials. 2000;23(2):155–9.

CAS  Google Scholar 

De Maria L, Terzi di Bergamo L, Conti A, Hayashi K, Pinzi V, Murai T, et al. CyberKnife for recurrent malignant gliomas: a systematic review and meta-analysis. Front Oncol. 2021;11:652646.

Article  Google Scholar 

Oehlke O, Mix M, Graf E, Schimek-Jasch T, Nestle U, Götz I, et al. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA)—protocol of a randomized phase II trial (NOA 10/ARO 2013–1). BMC Cancer. 2016;16(1):769.

Article  Google Scholar 

Minniti G, Niyazi M, Alongi F, Navarria P, Belka C. Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol. 2021;16(1):36.

Article  Google Scholar 

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

Article  CAS  Google Scholar 

Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, et al. Radiation therapy for glioblastoma: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology Guideline. J Clin Oncol. 2017;35(3):361–9.

Article  CAS  Google Scholar 

Mann J, Ramakrishna R, Magge R, Wernicke AG. Advances in radiotherapy for glioblastoma. Front Neurol. 2017;8:748.

Article  Google Scholar 

Kim IH. Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation. Radiat Oncol J. 2019;37(1):1–12.

Article  Google Scholar 

Bette S, Barz M, Huber T, Straube C, Schmidt-Graf F, Combs SE, et al. Retrospective analysis of radiological recurrence patterns in glioblastoma, their prognostic value and association to postoperative infarct volume. Sci Rep. 2018;8(1):4561.

Article  Google Scholar 

Weinberg BD, Boreta L, Braunstein S, Cha S. Location of subventricular zone recurrence and its radiation dose predicts survival in patients with glioblastoma. J Neurooncol. 2018;138(3):549–56.

Article  CAS  Google Scholar 

Seystahl K, Wick W, Weller M. Therapeutic options in recurrent glioblastoma: an update. Crit Rev Oncol Hematol. 2016;99:389–408.

Article  Google Scholar 

Le Rhun E, Rhun EL, Taillibert S, Chamberlain MC. The future of high-grade glioma: Where we are and where are we going. Surg Neurol Int. 2015;6(Suppl 1):S9-44.

Google Scholar